{"id":781854,"date":"2023-09-05T14:54:43","date_gmt":"2023-09-05T18:54:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/"},"modified":"2023-09-05T14:54:43","modified_gmt":"2023-09-05T18:54:43","slug":"brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/","title":{"rendered":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American &#8211; AGE), Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG)"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BALA CYNWYD, Pa., Sept.  05, 2023  (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hSF8GnWKet6xb9qv_LzX3EQg9o6sZzE-U9Nqc4jC9NTXZAsg1CiHPh68iSkSNpTuHAwJ6etNjLfGa4ZTvJrjQ7kKN7-sbciIwDYdVvURbfbdutpHiMijShK96ATwXZpG\" rel=\"nofollow noopener\" target=\"_blank\">jbrodsky@brodskysmith.com<\/a>) or Marc Ackerman (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jG6cmcCmZbpAVAphOtD2IPkIKbjxq2vWrK8sVm4aPJBnhRhM42WUbGvTn3_mxI9726Glnz93qOHZE3Zcy8YgggIUMg37ZCsXhQBvHPas5-AkVEaWhUEUm1EelltRv_bI\" rel=\"nofollow noopener\" target=\"_blank\">mackerman@brodskysmith.com<\/a>) at 855-576-4847. There is no cost or financial obligation to you.<\/p>\n<p>\n        <strong>AgeX Therapeutics, Inc. (NYSE American &#8211; AGE)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the Merger Agreement, AgeX will be acquired by Serina Therapeutics, Inc. (\u201cSerina\u201d). Serina will merge with a wholly owned subsidiary of AgeX, and stockholders of Serina will receive shares of AgeX common stock. Pre-merger AgeX stockholders are expected to own approximately 25% of the newly combined company while pre-merger Serina stockholders are expected to own approximately 75% of the newly combined company. The investigation concerns whether the AgeX Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Serina is paying fair value to shareholders of the Company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u7_F0yIFZejD72tfWuoRFUC5gVo91WR2EphAJNGh1IjL0TdVDE0ntBx7iK_DggA2l3zS-z2_z9vW3SGzgwOL0KE1-7XQ9ZQ3jEljkpJsv0XA9W0VFuO0TNJooa2XEaH0ezGJIZhc3g1a0xuZ7ls7LtgXIpkjkyOaIxl3pWKM9eDJkHRDvYtpvB2VdBWC85L5tRYuUwNw1gmku4OIoi6rJbZVMEFO6to7Z1z4jDVYi1E=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/agex-therapeutics-inc-nyse-american-age<\/a><\/p>\n<p>\n        <strong>Acer Therapeutics Inc. (Nasdaq &#8211; ACER) <\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the Agreement, Acer will be acquired by Zevra Therapeutics, Inc. (\u201cZevra\u201d) (Nasdaq &#8211; ZVRA). At closing, Zevra would issue 0.121 of a share of Zevra\u2019s common stock in respect of each share of Acer\u2019s common stock. In addition, Acer stockholders of record as of immediately prior to the effective time of the merger would receive non-transferable CVRs entitling the holders to receive up to $34 million in cash upon the achievement of certain commercial milestones for OLPRUVA, and up to an additional $42 million in cash upon the achievement of certain regulatory milestones for OLPRUVA and EDSIVO. The investigation concerns whether the Acer Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Zevra is paying fair value to shareholders of the Company.<\/p>\n<p>Additional information can be found at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u7_F0yIFZejD72tfWuoRFUC5gVo91WR2EphAJNGh1IiVl87cutDU6g7z3gl-H_wcmUXOfif1ka3Zrp41P7seGWUet09mw4rScp7oPW9UY6R9VFb2CBVxz0bv0RWM5Ad4Zh0hkxWtMMsPTVej7SCYItEL7O6MClnjmb7u7swpn8Xelhu7S3XKxr475KJgz7ACddERogp3vZh83s4dP15rxlq8GURfAOXwZ8am73pqPos=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/acer-therapeutics-inc-nasdaq-acer-2\/<\/a>.<\/p>\n<p>\n        <strong>Sovos Brands, Inc. (Nasdaq &#8211; SOVO)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the agreement, Sovos will be acquired by Campbell Soup Company (NYSE &#8211; CPB). Each share of Sovos common stock will be entitled to receive $23.00 per share in cash, representing a total enterprise value of approximately $2.7 billion. The investigation concerns whether the Sovos Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Campbell Soup is paying fair value to shareholders of the Company.<\/p>\n<p align=\"justify\">Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u7_F0yIFZejD72tfWuoRFUC5gVo91WR2EphAJNGh1IjRHCPhTd5eJiTVxVBW2D7fikDd4l6bU4LThofYyjwrOu9uhuEex451k0duS4AxuBR9HdBgfD9fE7FMWZcw83OySmGPiv_0KZ9JPpffbfWmXGf7Z3RymrDkD1Xoz29Ov5LBuZRTr4XsDypvyiOjqWdc8ftjRzFfgOOU7Vvj-qroqA==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/sovos-brands-inc-nasdaq-sovo\/<\/a>.<\/p>\n<p>\n        <strong>Computer Task Group, Incorporated (Nasdaq &#8211; CTG)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the agreement, CTG will be acquired by Cegeka Groep nv (\u201cCegeka\u201d). CTG shareholders will receive $10.50 per share of common stock in an all-cash transaction, representing an implied equity value of approximately $170 million. The investigation concerns whether the CTG Board breached its fiduciary duties to shareholders by failing to conduct a fair process resulting in Cegeka paying less than full value for the Company.<\/p>\n<p align=\"justify\">Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u7_F0yIFZejD72tfWuoRFUC5gVo91WR2EphAJNGh1IhTRZzBf3_X7Pw8emNg94mgkG9nTCxAu3_RX7jEy3T2739HEklfhkcnnAdsaHAHHq-doQOYc4Q12vrY9quflLrzbLV2Q70J6QNNajBTgzzOvluAkgiCwR8kNOAXy6BhfS-3cskPFajMFGNXSqAS8Hjal81NOy0P_Ts3oez28WBAYyBc2nSMZGSuGzm60EAR0Iu4LiNkaF_oD2Q2Jv9ZdkCZ\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/computer-task-group-incorporated-nasdaq-ctg\/<\/a>.<\/p>\n<p align=\"justify\">Brodsky &amp; Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky &amp; Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjg5MyM1Nzk5MzEwIzIxODgyNzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NWNiMWEyMTItZjc0OS00MmQyLWIyY2EtZmU3ZGFkZDY0NGFmLTExOTk4MzE=\/tiny\/Brodsky-Smith-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BALA CYNWYD, Pa., Sept. 05, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. AgeX Therapeutics, Inc. (NYSE American &#8211; AGE) Under the terms of the Merger Agreement, AgeX will be acquired by Serina Therapeutics, Inc. (\u201cSerina\u201d). Serina will merge with a wholly owned subsidiary of AgeX, and stockholders of Serina will receive shares of AgeX common stock. Pre-merger AgeX stockholders are expected to own approximately 25% of the newly combined company while pre-merger Serina stockholders are expected to own approximately 75% of the newly combined company. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American &#8211; AGE), Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-781854","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American - AGE), Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American - AGE), Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BALA CYNWYD, Pa., Sept. 05, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. AgeX Therapeutics, Inc. (NYSE American &#8211; AGE) Under the terms of the Merger Agreement, AgeX will be acquired by Serina Therapeutics, Inc. (\u201cSerina\u201d). Serina will merge with a wholly owned subsidiary of AgeX, and stockholders of Serina will receive shares of AgeX common stock. Pre-merger AgeX stockholders are expected to own approximately 25% of the newly combined company while pre-merger Serina stockholders are expected to own approximately 75% of the newly combined company. &hellip; Continue reading &quot;BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American &#8211; AGE), Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-05T18:54:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjg5MyM1Nzk5MzEwIzIxODgyNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American &#8211; AGE), Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG)\",\"datePublished\":\"2023-09-05T18:54:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\\\/\"},\"wordCount\":596,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNjg5MyM1Nzk5MzEwIzIxODgyNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\\\/\",\"name\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American - AGE), Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNjg5MyM1Nzk5MzEwIzIxODgyNzg=\",\"datePublished\":\"2023-09-05T18:54:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNjg5MyM1Nzk5MzEwIzIxODgyNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNjg5MyM1Nzk5MzEwIzIxODgyNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American &#8211; AGE), Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American - AGE), Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/","og_locale":"en_US","og_type":"article","og_title":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American - AGE), Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG) - Market Newsdesk","og_description":"BALA CYNWYD, Pa., Sept. 05, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. AgeX Therapeutics, Inc. (NYSE American &#8211; AGE) Under the terms of the Merger Agreement, AgeX will be acquired by Serina Therapeutics, Inc. (\u201cSerina\u201d). Serina will merge with a wholly owned subsidiary of AgeX, and stockholders of Serina will receive shares of AgeX common stock. Pre-merger AgeX stockholders are expected to own approximately 25% of the newly combined company while pre-merger Serina stockholders are expected to own approximately 75% of the newly combined company. &hellip; Continue reading \"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American &#8211; AGE), Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-05T18:54:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjg5MyM1Nzk5MzEwIzIxODgyNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American &#8211; AGE), Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG)","datePublished":"2023-09-05T18:54:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/"},"wordCount":596,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjg5MyM1Nzk5MzEwIzIxODgyNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/","name":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American - AGE), Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjg5MyM1Nzk5MzEwIzIxODgyNzg=","datePublished":"2023-09-05T18:54:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjg5MyM1Nzk5MzEwIzIxODgyNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjg5MyM1Nzk5MzEwIzIxODgyNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-agex-therapeutics-inc-nyse-american-age-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American &#8211; AGE), Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=781854"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781854\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=781854"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=781854"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=781854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}